Because bisphenol A (BPA) exposure is nearly ubiquitous, increased knowledge of its potential effects on development will enable better risk assessment and regulatory guidance. Here, Sprague-Dawley rats were reared in low exogenous estrogen environments. After breeding at adulthood, dams were gavaged on gestational days (GDs) 6-21 with vehicle (VEH), 2.5 or 25.0 mg/ kg/day BPA, or 5.0 or 10.0 mg/kg/day ethinyl estradiol (EE 2 ). Offspring were orally treated on postnatal days (PNDs) 1-21 with the same dose the dam received. Relative to the VEH group, dams of both EE 2 -treated groups weighed less throughout gestation and lactation. PND 1 absolute anogenital distance and anogenital index were unaltered by any treatment. Ages at fur development and eye and ear opening were unaffected by any treatment. Despite a significant treatment effect, no group was significantly different from VEH in PNDs 3-6 righting latencies; although males had shorter latencies and all latencies decreased with age. PNDs 8-11 slant board behavior was unaffected by any treatment; however, males had shorter turning latencies and latencies decreased with age. Preweaning body weights of BPA-and EE 2 -treated groups as well as naive controls were less than VEH. No treatment affected PND 21 whole or regional brain weights or levels of estradiol, testosterone, corticosterone, T3, T4, luteinizing hormone, ghrelin, or leptin. These results add to the literature indicating that developmental BPA treatment at these doses has no effects on gestational or lactational body weight, offspring anogenital distance, preweaning behaviors or hormone levels, and whole and regional brain weights measured at weaning.
Human exposure to the plastic monomer bisphenol A (BPA) is nearly ubiquitous with more than 90% of the U.S. and Canadian populations exhibiting measurable urinary levels (Bushnik et al., 2010; Calafat et al., 2008) . The primary route of BPA exposure appears to be oral from food contact materials (Kang et al., 2006; von Goetz et al., 2010) , and daily intake for adults is estimated at 0.4-1.4 lg/kg/day (Food and Agriculture Organization of the United Nations, World Health Organization, 2010). Estimates of intake for infants are higher, however, ranging 0.01-2.4 lg/kg/ day, with infants fed exclusively using polycarbonate baby bottles having higher levels (Food and Agriculture Organization of the United Nations, World Health Organization, 2010).
Although recent reviews and perspectives have noted varying levels of concern regarding the potential risks of BPA exposure (for a review of those risk assessments, see Beronius et al., 2010) , most agree that there is at least some level of concern for neurobehavioral effects which may result from developmental BPA exposure. In part, this concern is a consequence of the higher BPA exposure levels in infants and children. However, BPA is thought to act by perturbing endocrine systems (reviewed in Wolstenholme et al., 2011) , and normal development of these systems is essential for appropriate neural and behavioral sexual differentiation and dimorphisms (for reviews, see Cooke et al., 1998; Morris et al., 2004) . Thus, exposure to an endocrine disrupter during development could have severe and/or long-lasting effects.
There are many studies examining developmental BPA exposure in laboratory animals (for reviews of these, see Goodman et al., 2006; Palanza et al., 2008; Richter et al., 2007) , but these have often generated inconsistent results. In response, explicit guidelines for future BPA research have been described. Those suggested standards include use of a sensitive positive control or reference estrogen (Hunt et al., 2009; Li et al., 2008) such as ethinyl estradiol (Richter et al., 2007) , control of exogenous estrogens (Hunt et al., 2009) , statistical control for litter effects (Goodman et al., 2006; Li et al., 2008; Richter et al., 2007) , and use of oral administration for the most relevant extrapolation to humans (Li et al., 2008; Richter et al., 2007) . That last recommendation could be troublesome for laboratory animal research. Orogastric gavage is the most typical form of oral administration for rodents but can be stressful (Balcombe et al., 2004) . Gestational stress can result in later alterations in offspring behavior (reviewed in Buynitsky and Mostofsky, 2009; Maccari and Morley-Fletcher, 2007; Weinstock, 2001 ); thus, control or evaluation of this potential confound would be beneficial.
The suggested guidances above were incorporated into the current study design in which pregnant Sprague-Dawley rats were housed in controlled environments, which contributed minimal levels of exogenous estrogen exposure. Dams were treated orally via gavage with vehicle, BPA (2.5 or 25.0 lg/kg/ day), or EE 2 (5.0 or 10.0 lg/kg/day). An additional control group was included (termed here, naive control) in which the animals were not gavaged to control for potential stress effects. Although lactational transfer of BPA has been demonstrated in Sprague-Dawley rats, the amount delivered to the offspring was reported as 300-fold lower than that administered to the dams (Doerge et al., 2010b) . Thus, in order to more accurately control dose and better mimic bottle-fed infants who, relative to breast-fed infants, are estimated to have increased BPA intake (Lakind and Naiman, 2008; von Goetz et al., 2010) , the offspring were directly orally treated beginning on postnatal day (PND) 1 until weaning at PND 21. Most lacking in the BPA literature are reports of potential BPA-induced alterations of early behaviors (but see Ema et al., 2001; Palanza et al., 2002; Stump et al., 2010 for lack of BPA effects on the righting reflex and cliff aversion). Here, we describe the effects of developmental BPA or EE 2 treatment on dam and offspring body weight, dam food/water intake, offspring anogenital distance, offspring age at developmental landmark occurrence (i.e., ear and eye opening), offspring whole and regional brain weights and hormonal levels at weaning, and performance of two preweaning behaviors of offspring (righting reflex and slant board behavior). Those preweaning behaviors were previously shown to be sensitive to developmental EE 2 treatment (Arabo et al., 2005) . Internal measures of BPA are not described here; however, several studies have measured serum BPA levels after oral administration to adult and neonatal rats (Doerge et al., 2010a; Tominaga et al., 2006; Xiao et al., 2006) .
MATERIALS AND METHODS
Animals. The National Center for Toxicological Research (NCTR) Breeding Colony supplied 364 female and 180 male Sprague-Dawley rats (derived from Charles River Crl: COBS CD (SD) BR Rat, Outbred) at weaning (PND 21). Upon reaching breeding age (see below), these rats became the dams and sires (i.e., F 0 generation) of subsequent litters. Upon arrival to the vivarium at PND 21, each rat was tail tattooed for identification, weighed, and group-housed (three same-sex/cage). Ad lib food (see below for diet information) and water were provided at all times. Housing rooms were maintained on a 12/12-h light/ dark cycle (6 A.M.-6 P.M.) at 22 ± 1°C (mean ± SE) and 45-55% humidity. All animal procedures followed the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) and were approved in advance by the NCTR Institutional Animal Care and Use Committee.
Housing environments. Upon arrival at PND 21, rats were housed in polysulfone cages with polysulfone microfilter tops, both of which were purchased new at the beginning of the study (Ancare, Bellmore, NY). Polysulfone caging was chosen as no detectable in vivo or in vitro estrogenic effects from BPA extracted from new polysulfone cages have been observed (Howdeshell et al., 2003) . Analysis by high-performance liquid chromatography (HPLC) in the Division of Biochemical Toxicology/NCTR of new polysulfone cages filled with ammoniated water (pH 8, to duplicate urine) for 64 h indicated only a trace of BPA at a 1 ppb limit of quantitation (Siitonen, unpublished data) . Further analysis by liquid chromatography tandem mass spectrometry indicated that new polysulfone cages leached 0.088 ppb BPA and, after three or nine washes, the leachate contained less than 0.030 ppb (Siitonen, unpublished data). Glass water bottles with food-grade silicone stoppers (Fisher Scientific, St Louis, MO) and metal sipper tubes were used to further reduce potential environmental estrogen exposure. Background BPA in the woodchip bedding material was determined in two different samples by liquid chromotography electrospray ionization mass spectrometry (LC-ESI-MS) utilizing d 6 -BPA and ranged 0.29-1.75 ppb (Siitonen, unpublished data). Metal mop buckets were used in the housing rooms, and all chow was stored in metal containers. This environment was maintained for the F 0 generation beginning at PND 21 and throughout the remainder of the study.
Diet. Beginning upon arrival from the NCTR Breeding Colony at PND 21 and throughout the study, all animals were maintained on a low-phytoestrogen chow (TestDiet 5K96 [irradiated pellets], Verified Casein Diet 10 IF; TestDiet, Richmond, IN). LC/MS analysis by the Division of Biochemical Toxicology indicated low levels of daidzein (< 0.34 ppm) and genistein (< 0.58 ppm) in three separate diet samples (Siitonen, unpublished data). Further, five different lots of diet were analyzed for BPA levels by LC-ESI-MS utilizing d 6 -BPA. These diets averaged 2.34 ± 0.43 (mean ± SE) ppb BPA (Siitonen, unpublished data).
Breeding. There were nine breeding rounds, each one consisting of a 24-h pairing of a male and female, with a 2-week interval between each round. Male and female breeders were those that were obtained at PND 21, housed in polysulfone cages with glass water bottles, and fed low-phytoestrogen chow as described above. Male/female pairings were random subject to the constraint that no grandparent could be shared within a pair (i.e., no pairings were done between siblings, first, or half cousins). Beginning on PND 87 or 90, each female was placed into a wire bottom cage with a PND 90 male that had been placed into the cage 72 h earlier for habituation. The pair was housed together for 24 h, after which the female and the cage bottom were visually examined for a sperm plug. If a sperm plug was detected, the female was removed, weighed, and housed individually, and this day was termed as gestational day (GD) 0. If no sperm plug was detected, the female was returned to her home cage and used in the next breeding round (2 weeks later). If no sperm plug was detected after two breeding rounds, the female was euthanized. Males were used for a maximum of three breeding rounds after which they were euthanized. Because all breeding occurred prior to any treatment, breeding success or failure was unrelated to treatment. Treatment assignment. Females for which a sperm plug was detected were randomly assigned to treatment within their body weight stratum. The early strata were quartiles of all plug-positive dams. However, it became evident early in the study that probability of littering given sperm plug detection was related to body weight. Therefore, later strata were determined from the body weight quartiles of littering dams from the early breeding rounds. The six treatment groups were forced to be approximately balanced within each body weight stratum as the breeding rounds occurred.
Drugs. Bisphenol A (2,2-Bis(4-hydroxyphenyl)propane, Product #B0494; TCI America) and EE 2 (17a ethinyl estradiol, Product #E4876; Sigma, St Louis, MO) were each dissolved in a 0.3% (by weight) aqueous solution of carboxymethylcellulose sodium salt (CMC, high viscosity) (Product #C5013; Sigma). The purity of TCI America Lot # 111909 BPA was determined to be > 99% by HPLC-PDA and proton NMR (Siitonen, unpublished data) . Because of the lipophilic nature of BPA, oils (e.g., corn oil, tocopherol-stripped corn oil, arachis oil) are often used as vehicle. However, suggestions that such oils could possess 150 FERGUSON, LAW, AND ABSHIRE estrogenic activity (see Ashby and Lefevre, 1997; Ryan, 2005) and their nutritive potential have discouraged their use (Ashby and Lefevre, 1997) . Thus, an aqueous vehicle was chosen for use here, which also offered the advantage of using automated dosing pumps (see below). Random BPA and EE 2 gavage solutions were analyzed via HPLC-PDA and results ranged 105 ± 5% and 99 ± 8% (mean ± SD), respectively, of the intended targeted concentrations (Siitonen, unpublished data).
BPA and EE 2 treatment. BPA dose selection was based on the estimated daily intake for adults and infants (see Introduction) as well as a ''worst-case estimate'' of intake of 11.0 lg BPA/kg/day for infants up to 6 months of age (Scientific Panel on Food Additives F, Processing Aids and Materials in Contact with Food, 2006) . Here, 25.0 lg BPA/kg/day was selected as the higher dose and 2.5 lg BPA/kg/day as a lower dose.
Beginning on the morning of GD 6, dams were gavaged with 5.0 ml 0.3% CMC/kg/day (vehicle control group), 2.5 lg BPA/kg/day (low-BPA group), 25.0 lg BPA/kg/day (high-BPA group), 5.0 lg EE 2 /kg/day (low-EE 2 group), or 10.0 lg EE 2 /kg/day (high-EE 2 group) using a Hamilton Microlab 500 system (Hamilton Company, Reno, NV) interfaced with an animal weight scale and animal data collection software developed at the NCTR. An automated algorithm calculated the necessary volume (5 ml/kg) based on the daily body weight of each rat. Daily oral gavage of the dams continued through GD 21 (the day prior to parturition). Dams in the naive control group were removed from their home cage and restrained in the gavage position for the same duration as would be used for a gavage but were not gavaged. Thus, there were six treatment groups: (1) naive control, (2) vehicle control, (3) low-dose BPA, (4) high-dose BPA, (5) low-dose EE 2 , and (6) high-dose EE 2 .
Dams were not treated on the day of parturition (typically, GD 22) and were left undisturbed on that day. On the day after parturition (PND 1), the eight offspring in each litter (after culling, tattooing, and anogenital measures, see below) were orally treated with the same dose as their dam had received. Gavage volume remained the same (5 ml/kg). Daily oral treatment of offspring continued through PND 21. For offspring in the naive control group, each was removed from their home cage and restrained in the gavage position for the same duration as would be used for a gavage but were not gavaged. Offspring were directly treated, rather than continuing treatment of the dams to allow potential lactational transfer to the pups, because only small amounts of BPA are present in milk relative to concentrations in the serum of the dam (Doerge et al., 2010b) . Furthermore, direct treatment of the offspring more closely mimics human BPA exposure through infant care bottles and infant formula cans as well as allowing increased dose accuracy.
PND 1 litter treatment and measures. Many of the assessments reported here require measurement over several consecutive days. For testing efficiency, any dam that littered early (before GD 22) or late (after GD 22) was not maintained beyond lactational day (LD) 1; however, litter data (e.g., total number of pups, sex ratio) were included for those subjects. Additionally, because treatment could affect gestation duration, those dams are included for that endpoint as well. On the day after parturition, all pups/litter were weighed, sexed, and each litter was randomly culled to eight pups (four/sex/litter where possible). Fostering was occasionally necessary and always done within treatment groups. Retained pups, including fostered pups, were paw tattooed on PND 1 for identification. Litter endpoints included gestation duration, total number of pups/litter, number of live pups/litter, live sex ratio (males/total live pups), and total sex ratio (including dead pups) (males/total pups). Birth weight (PND 1) analysis included all pups (pre-culling) for those litters on which parturition occurred on GD 22. Birth weights were first averaged for males/litter and females/litter prior to analysis.
Uteri of dams that did not litter by estimated GD 26 were examined at necropsy and numbers of grossly visible resorption sites (uterine scars) were counted. Subsequently, uteri were placed in 10% ammonium sulfide for at least 15 min, removed, rinsed, and placed on a light table for transillumination to determine any embryo implants that died before resorption sites were formed.
Body weight and food and water intake. Dams were weighed on GD 0 and daily beginning on GD 6 (before treatment) until pup weaning on LD 21. Food and water intake were measured daily beginning on GD 6 until LD 21.
Body weight and food and water intake for those dams that did not litter or delivered early or late were deleted prior to statistical analyses. Offspring were weighed daily through PND 21.
Anogenital distance and anogenital distance index. Anogenital distance (AGD) (millimeters) of all retained offspring/litter was measured on PND 1 using a dissecting microscope by a trained technician blind to treatment group. Each subject was measured in triplicate, but the three readings were not done consecutively. Offspring in a litter were randomly selected for a first measurement until the litter was completed and then all offspring were remeasured again for the second reading and so on. Of 734 offspring measurements (or 2202 readings), 30% produced the same measure over the three readings. The maximum difference in any of the three individual subject readings was 0.8 mm, and this occurred in only two subjects, indicating very little variability in the three readings for each subject. The average of the three measures for each offspring was first calculated and then the average AGD for males/litter and females/litter was calculated. To normalize for potential differences in body weight, the AGD index (AGD distance in mm/cube root of body weight) (Christiansen et al., 2009 ) was calculated for each individual offspring using the average of the three AGD readings, followed by calculation of the average AGD index for males/litter and females/litter. Dividing by the cube root of body weight is a more appropriate normalization as it does not overcompensate for differences in body weight (Gallavan et al., 1999) . Thus, each litter contributed two data points for absolute AGD (male and female) and two data points for AGD index (male and female).
Developmental landmarks. Beginning on PND 1, all offspring/litter were examined daily for bilateral ear canal opening, bilateral eye opening, and fur development. Age (PND) at reaching each of these milestones was recorded for each subject and then averaged for males/litter and females/litter such that each litter contributed two data points for each landmark. On PND 13, male pups were examined for nipple retention and recorded as either no retention or number of nipples retained.
Righting reflex. On PNDs 3-6, all offspring/litter were assessed for the righting reflex as previously described (Ferguson et al., 2010) . Briefly, each pup was placed dorsal side down on a flat surface and the latency to right onto all four paws was recorded using a hand-held stopwatch (maximum latency 60 s). One trial/day was conducted by trained testers blind to treatment. Latency to right was averaged for males/litter and females/litter for each PND prior to analysis.
Slant board behavior. On PNDs 8-11, all offspring/litter were assessed for slant board behavior as previously described (Ferguson et al., 2010) . Briefly, each pup was placed ventral side down on a sandpaper-covered board angled at 45°with the head pointed downward. Latency to turn 180°was measured using a hand-held stopwatch (maximum latency 60 s). Time of fall was recorded if the pup fell from the apparatus. One trial/day was conducted by trained testers blind to treatment.
PND 21 serum hormone measures. Beginning at 8:30 A.M. on PND 21 after the last oral treatment, one offspring/sex/litter was lightly anesthetized with CO 2 after which blood was collected via cardiac puncture. The maximum duration between the first and last blood sample was 135 min (i.e., blood collection typically began at 8:30 A.M. and at its latest, ended at 10:45 A.M.). Euthanasia occurred with additional CO 2 . Samples were allowed to clot and then centrifuged. Serum was removed and stored at À80°C until analysis.
Many of the hormones measured here exhibit significant circadian rhythms (e.g., Kalra and Kalra, 1977; Mock et al., 1978) and some are quite low in young animals. For example, serum levels of luteinizing hormone (LH) are low in prepubertal male rats (Dohler and Wuttke, 1976) . Still, given the previously described effects of developmental BPA on rodent serum LH levels (Akingbemi et al., 2004; Cardoso et al., 2010; Nakamura et al., 2010) , it was important to obtain this measure at this age. Serum samples were obtained during the early portion of the light period during as short a duration as possible. Samples could not be obtained earlier on that day (i.e., PND 21) as the offspring must be orally gavaged prior to blood collection. The selection of a morning sample was done FEW EFFECTS OF DEVELOPMENTAL BPA OR EE 2 151 for convenience because other measures were also obtained on that day (i.e., brain removal and weights), although it is understood that some hormone levels may be low at this time (e.g., testosterone) (Grotjan and Johnson, 1976) .
Total thyroxine (T4), total triiodothyronine (T3), total estradiol (E 2 ), total testosterone, corticosterone, and LH were analyzed in duplicate with Siemens radioimmunoassay reagents (Los Angeles, CA) and counted on a PerkinElmer Cobra 5005 Gamma Counter (Shelton, CT). Leptin (Millipore rat leptin ELISA, Billerica, MA) and total ghrelin (Linco rat/mouse ghrelin ELISA, St Charles, MO) were analyzed via ELISA and read on a BioTek EL808 microplate reader (Winooski, VT). The ELISA results were calculated with the instrument's data reduction software using a sigmoidal 4-parameter logistic equation. The radioimmunoassay results were calculated with the instrument's data reduction software from a logit-log representation of the linear calibration curve. All maintenance was performed according to the manufacturer's recommendations. The gamma counter was calibrated and normalized. Two levels of assayed controls were included in each assay as internal controls.
A standard curve was generated for each assay. Correlation coefficients obtained were total T4 (0.9996), total T3 (0.9964), total E 2 (0.9991), total testosterone (0.9954), corticosterone (0.9986), and LH (1.0000). Ghrelin levels had an inter-assay coefficient of variation of 3.31% and the coefficient of variation for leptin levels was 3.93%.
PND 21 whole and regional brain weights. After blood was collected for serum hormone measures (see above) and each subject was euthanized, the whole brain was removed and weighed. Frontal cortex and hippocampus were dissected as previously described (Ferguson et al., 1993) and weighed. Absolute whole brain, frontal cortex, and hippocampal weights were subjected to analysis as were weights adjusted for body weight (whole brain weight/body weight, frontal cortex weight/body weight, and hippocampal weight/body weight).
Statistical analyses. Litter was the experimental unit in all analyses. Fostered pups were treated identically with regard to behavioral assessments and other measures, but data from these subjects were not included in any statistical analysis.
All repeated measures analyses were conducted using SAS (version 9.2; SAS Institute Inc., Cary, NC). Simple one-or two-way ANOVAs (with factors of treatment and/or sex) were conducted using SigmaStat (version 3.11.0; Systat Software Inc., San Jose, CA). Significant interactions were further analyzed using appropriate comparisons to compare each treatment group with the vehicle control group. For data sets in which there was a repeated measure (e.g., body weights), within-group correlations were modeled using the heterogeneous AR1 correlation structure (Littell et al., 1996) . When data were not normally distributed, a log transform or an ANOVA on ranks (i.e., Kruskal-Wallis ANOVA) was conducted. Statistical significance was defined as p < 0.05. Specific information for each endpoint is described below.
Dam gestational body weights and food and water intake were analyzed separately from lactational measures as not all litters were retained on study after birth (see footnotes in Table 1 and results of Pregnancy Rates and Early Deaths). Gestational body weights were analyzed via repeated measures analysis of covariance (ANCOVA) using GD 0 body weight as a covariate with factors of treatment and GD. Dam lactational body weights were analyzed via repeated measures ANCOVA using GD 0 body weight as a covariate with factors of treatment and LD. Gestational food consumption and water intake were analyzed via repeated measures ANOVA with factors of treatment and GD. Lactational food and water intake were similarly analyzed. Pairwise comparisons to the vehicle control group for each day, and overall, were performed using Dunnett's test.
Because litters were culled, birth weights (PND 1), which included all pups/litter before culling, were analyzed separately from PND 1-22 body weights, which included only retained pups. Birth weights were analyzed with a two-way ANOVA with factors of treatment and sex. Significant effects were further analyzed using the Holm-Sidak method. PND 1-22 body weights of retained pups were analyzed separately for males and females using repeated measures ANOVAs with factors of treatment and PND. Pairwise comparisons to the vehicle control group for each day, and overall, were performed using Dunnett's test.
Offspring deaths before PND 21 were analyzed for the effects of treatment, sex, and the interaction using a Cox proportional hazards regression with the robust sandwich estimate for the covariance matrix based on litters. Offspring that survived until PND 21 were censored at that age. Pairwise comparisons were adjusted using Holm's adjustment for multiple comparisons. An offspring was recorded as dead if it was found dead in the home cage or it was missing and presumed cannibalized. This analysis does not include any offspring that were euthanized, the offspring of the naive control dam, which killed her pups on PND 2, or the high BPA dose dam that cannabilized her pups on PND 1 (see Table 1 ).
AGD and AGD index were analyzed separately for males and females, using separate one-way ANOVAs. Pairwise comparisons to the vehicle control group were performed using Dunnett's test. Developmental landmark data were analyzed for each sex separately using one-way ANOVAs with the factor of treatment. Pairwise comparisons to the vehicle control group were performed using Dunnett's test. Nipple retention was not noted in any male offspring; thus, this endpoint was not analyzed.
Righting reflex data (i.e., latency to right) were not normally distributed; thus, a natural log transformation was applied to reduce skewness. A repeated measures ANOVA with factors of treatment, sex, PND, and all interactions was used to analyze the log latency time. Pairwise comparisons to the vehicle control group for each day, and overall, were performed using Dunnett's test.
To analyze the latency to turn time on the slant board behavior test, a Cox proportional hazards model (Kalbfleisch and Prentice, 2002) was performed with treatment, sex, PND, and all interactions as factors. This type of analysis adjusts for failure, here, defined as failure to turn or falling from the apparatus. Use of a Cox proportional hazards model is recommended for latency outcomes in behavioral endpoints as it appropriately handles failure and the underlying data distribution is not relevant (Jahn-Eimermacher et al., 2011) . Pairwise comparisons to the vehicle control group for each day, and overall, were performed using Holm's adjusted contrasts.
PND 21 serum hormone concentrations and whole and regional brain weights were analyzed via separate two-way ANOVAs with treatment and sex as factors. Some serum hormone concentrations were below the limit of detection. For analysis, these data were set to the detection limit.
RESULTS

Differences between the Vehicle Control and Naive Control
Groups Regardless of the overall significance of a main effect or interaction in the analysis, inspection of all pairwise comparisons indicated that there were only two statistically significant differences between the naive control and vehicle control groups. Preweaning body weight (i.e., PND 1-22) of offspring indicated a significant difference between the naive control and vehicle control groups (described below), and on GD 20, dams of the naive control group had a significantly higher water intake than the vehicle control group (described below). No other pairwise comparison yielded a significant difference between these two groups.
Pregnancy rates and early deaths. With the exception of one low-dose BPA-treated dam with three implantation sites, no sperm plug-positive female that did not litter exhibited any implantation or resorption sites. Thus, BPA and EE 2 treatment, which began on GD 6, did not appear to affect pregnancy rates.
One high-dose BPA dam became moribund on GD 17. At necropsy, a pharynx perforation was present, likely due to a gavage accident. The uterus of this dam contained 13 fetuses and 2 implantation sites. Body weight and food and water 152 FERGUSON, LAW, AND ABSHIRE intake data from this dam were included in analyses through GD 17. One low-dose EE 2 dam died during parturition. At necropsy, five full-term fetuses were present in the uterus, and the lumen of the stomach was dilated and contained gas and ingested placental fragments. The oral cavity was filled with a large placental fragment, strongly suggesting that the cause of death was choking. Data from this dam were included in gestational analyses only.
The litter of one low-dose EE 2 dam contained only two pups (one per sex). The male pup was fostered after which the dam and female pup were euthanized. Two dams (one each from the naive control and high-dose BPA groups) killed all pups in their respective litters on PND 1 or 2 after culling and tattooing; these two dams were euthanized. Gestational and litter results data were retained in analyses from these three dams.
One dam in the low-dose BPA group with nine live offspring had breathing difficulties on LD 2. The dam and offspring were euthanized, but gestational and litter results data were retained in the analyses. A necropsy performed on the dam did not indicate any gross lesions, and the cause of moribundity was undetermined.
Thirty-five offspring died or were missing (and presumed cannibalized) prior to PND 21: none in the naive control group, three males and five females in the vehicle control group, five males and eight females in the low-dose BPA group, four males and one female in the high-dose BPA group, one male in the lowdose EE 2 group, and three males and five females in the high-dose EE 2 group. Pairwise comparisons indicated that relative to the number of vehicle control female deaths, fewer naive control females died (p < 0.001) and fewer low EE 2 females died (p < 0.001). Relative to the number of vehicle control male deaths, fewer naive control males died (p < 0.001). There were no other significant pairwise comparisons to the vehicle control group.
Litter results. Litter results are shown by treatment group in Table 1 . Twenty-nine pups were fostered within treatment to maintain a 4/sex/litter composition. Litters that received fosters were three naive control, four vehicle control, four low-dose BPA, one high-dose BPA, four low-dose EE 2 , and two2 highdose EE 2 . Duration of gestation was not normally distributed and an ANOVA performed on ranks indicated a significant effect of treatment (H ¼ 15.49, 5 d.f., p ¼ 0.008). However, Dunn's method of multiple comparisons indicated that no treatment group differed significantly from the vehicle control group. Total pups/litter (alive and dead) and total live pups/ litter were not normally distributed, and ANOVAs performed on ranks did not indicate a significant effect of treatment for either endpoint. Analysis of total sex ratio (including dead pups) indicated a significant treatment effect (F(5, 117) ¼ 2.43, p < 0.039); however, no treated group was significantly different from the vehicle control group. Analysis of live sex ratio did not indicate a significant treatment effect.
Analysis of PND 1 offspring body weights (before culling) indicated significant effects of treatment (F(5, 180) ¼ 3.74, p < 0.003) and sex (F(1, 180) ¼ 21.64, p < 0.001). Pairwise comparisons indicated that pups of the high-dose EE 2 group (10.0 lg/kg/day) weighed less than those of the vehicle control group (p < 0.01) and males weighed more than females (see Table 2 ). These data include all dams that littered, regardless of the day of littering (i.e., early and late litters are included). Gestation duration indicated a significant treatment effect (p ¼ 0.008); however, no-treatment group was significantly different from the vehicle control group. c Analysis of total sex ratio indicated a significant treatment effect (p < 0.039); however, no group was significantly different from the vehicle control group. Six females littered 1 day early and were not maintained further; one female killed all pups on PND 2. e Three females littered 1 day early and were not maintained further.
f One female littered 1 day early and was not maintained further; one female delivered nine pups and became moribund on LD 1 (see text for details).
g Four females littered 1 day early and three females littered 1 day late and were not maintained further; one female became moribund on GD 12 (see text for details); one female cannabilized all pups on PND 1. h Five females littered 1 day early and one female littered 1 day late and were not maintained further; one female died during parturition (see text for details); one female delivered only two pups and was not maintained further. Two females littered 1 day early and one female littered 1 day late and were not maintained further.
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Dam body weight and food and water intake. The ANCOVA for gestational body weight indicated significant main effects of treatment (F(5, 92) ¼ 8.69, p < 0.001) and GD (F(14, 1297) ¼ 206.64, p < 0.001). Pairwise comparisons to the vehicle control group indicated that gestational body weights of the two EE 2 groups were significantly less than that of the vehicle control group (p < 0.002 for the 5.0 lg EE 2 /kg/day and p < 0.008 for the 10.0 lg EE 2 /kg/day) (see Fig. 1, top) . The significant effect of GD indicated that all subjects gained weight with increasing gestation. Analysis of dam lactational body weight indicated significant main effects of treatment (F(5, 86) ¼ 5.39, p < 0.0003) and day (F(20, 1733) ¼ 18.51, p < 0.0001) (see Fig. 1, bottom) . Pairwise comparisons to the vehicle control group indicated that the highdose EE 2 group weighed less than the vehicle control group (p < 0.002). The significant effect of day indicated that all subjects gained weight during the first two lactational weeks.
Analysis of gestational food intake indicated a significant interaction of treatment 3 day (F(70, 1291) ¼ 1.33, p < 0.039) (see Supplementary figure 1 ). Pairwise comparisons indicated that the two EE 2 groups consumed less food than the vehicle control group on GDs 8 and 10-13 (p < 0.031 for all comparisons). Similarly, analysis of lactational food intake indicated a significant interaction of treatment 3 day (F(100, 1732) ¼ 1.49, p < 0.002) (see Supplementary figure 2). Pairwise comparisons indicated that the low-dose BPA group consumed less food than the vehicle control group on LDs 10, 15, 16, and 18 (p < 0.027 for all comparisons). On LDs 13 and 21, the high-dose EE 2 group consumed less food than the vehicle control group (p < 0.046 for both days).
Analysis of gestational water intake indicated a significant treatment 3 day interaction (F(70, 1298) ¼ 1.36, p < 0.029) (data not shown). Pairwise comparisons indicated that the highdose EE 2 group drank less water than the vehicle control group on GD 18 (p < 0.025). On GD 20, the naive control group drank less water than the vehicle control group (p < 0.012). Analysis of lactational water intake indicated a main effect of day (F(20, 1738) ¼ 113.42, p < 0.001), indicating that water intake increased as the lactation period progressed.
PND 1-21 offspring body weight. Analysis of male offspring body weight indicated significant main effects of treatment (F(5, 85) ¼ 34.27, p < 0.001) and PND (F(20, 1700) ¼ 2896.78, p < 0.001) (Fig. 2, top) . Similarly, analysis of female offspring body weight indicated significant main effects of treatment (F(5, 84) ¼ 10.90, p < 0.001) and PND (F(20, 1680) ¼ 2286.41, p < 0.001) (Fig. 2, bottom) . Pairwise comparisons to the vehicle control male offspring group indicated that all other same-sex groups (naive control, low-and high-dose BPA, low-and high-dose EE 2 ) weighed significantly less (p < 0.001 for all). Pairwise comparisons to the vehicle control female offspring group indicated that the naive control, low-and high-dose BPA, and high EE 2 dose groups weighed significantly less (p < 0.003 for all) (see also Supplementary figure 3 for individual litter averages).
AGD and AGD index. There were no significant effects of treatment on absolute AGD of males or females. Analysis of AGD index (AGD/cube root of body weight) of males indicated a significant effect of treatment (F(5, 89) ¼ 2.43, p < 0.041). However, pairwise comparisons indicated that no treatment group was significantly different from the vehicle control group. Analysis of AGD index in females did not indicate a significant treatment effect. Table 2 shows absolute AGD and AGD index by sex and treatment group.
Developmental landmarks. Age at bilateral eye opening, ear opening, and fur development were not significantly affected by treatment (see Supplementary table 1) . No male offspring in any treatment group exhibited any retained nipples at PND 13.
Righting reflex. Analysis of latency to right indicated significant main effects of treatment (F(5, 87) ¼ 2.60, p < 0.031), sex (F(1, 87) ¼ 7.93, p < 0.006), and PND (F(3, 261) ¼ 109.57, p < 0.001) (see Supplementary figure 4). Pairwise comparisons did not indicate that any treatment group was significantly different from the vehicle control group. Overall, however, males exhibited a significantly faster latency to right than females and latencies to right significantly decreased with age (i.e., increasing PND). AGD and AGD index were measured on PND 1 after culling (only those pups maintained in each litter) (n ¼ 13-19 litters/treatment group).
c Analysis of AGD index of males indicated a significant effect of treatment (p < 0.041); however, no group was significantly different from the vehicle control group. figure 5 ). Males turned significantly faster than females and latency to turn decreased with age (i.e., increasing PND). There were neither any effects of treatment nor any significant interactions with treatment.
PND 21 serum hormone measures. Mean ± SE of these data by treatment and sex are shown in Table 3 . Analyses of serum concentrations of T4, E 2 , LH, ghrelin, and leptin did not indicate significant effects of treatment, sex, or a treatment 3 sex interaction. Analysis of T3 concentrations indicated a main effect of treatment (F(5, 149) ¼ 2.46, p < 0.035) but no significant effect of sex or a treatment 3 sex interaction; pairwise comparisons, however, indicated that no-treatment group was significantly different from the vehicle control group. Analysis of corticosterone levels indicated a marginal effect of treatment (F(5, 149) ¼ 2.25, p < 0.052) with somewhat higher levels in the high-dose EE 2 group. A marginal effect of sex (F(1, 149) ¼ 3.74, p < 0.055) on testosterone levels indicated somewhat higher levels in males.
PND 21 whole and regional brain weights. Mean ± SE of these data by treatment and sex are shown in Supplementary table 2. Analysis of whole brain weight indicated a significant effect of sex (F(1, 149) ¼ 13.71, p < 0.001), indicating that brain weights of males were heavier than those of females. There was neither FIG. 1. Body weight (mean ± SE) of dams. Top: Gestational body weight expressed as percentage of GD 0 body weight. A main effect of treatment indicated that body weights of dams in the 5.0 and 10.0 lg/kg EE 2 groups were significantly less than that of dams in the vehicle control group. Mean (± SE) GD 0 body weights for dams in the naive control, vehicle control, 2.5 lg/kg BPA, 25.0 lg/kg BPA, 5.0 lg/kg EE 2 , and 10.0 lg/kg EE 2 groups were 287.0 ± 6.3, 287.5 ± 5.0, 280.4 ± 6.2, 289.7 ± 3.6, 291.7 ± 7.1, and 284.0 ± 5.2 g, respectively. Bottom: Lactational body weight expressed as percentage of GD 0 body weight. A significant effect of treatment indicated that body weight of dams in the 10.0 lg/kg EE 2 group was significantly less than that of dams in the vehicle control group.
FIG. 2.
Offspring body weights (mean ± SE). Top: Males. Bottom: Females. Pairwise comparisons of the significant treatment effects for males (F(5, 85) ¼ 34.27, p < 0.001) and females (F(5, 84) ¼ 10.90, p < 0.001) indicated that all male treatment groups weighed significantly less than the male vehicle control group (p < 0.001 for all) and that the naive control, low-and high-dose BPA, and high-dose EE 2 groups weighed significantly less than the female vehicle control group (p < 0.003 for all). Additional figures showing individual litter means are available in the Supplementary Online Data.
FEW EFFECTS OF DEVELOPMENTAL BPA OR EE 2 155 a significant effect of treatment nor a significant treatment 3 sex interaction. Analysis of frontal cortex and hippocampal weights did not indicate significant effects of treatment, sex, or significant interactions of treatment 3 sex.
Analyses of whole brain, frontal cortex, and hippocampal weights as ratios to body weight did not indicate any significant effects of treatment or sex or any significant interactions of treatment 3 sex.
DISCUSSION
Oral BPA treatment of pregnant Sprague-Dawley rats followed by direct oral treatment of their offspring had no effects on gestational or lactational body weight and only sporadic effects on food intake. Offspring AGD, AGD index, developmental landmarks, measures of serum hormones, and whole/regional brain weights were unaffected by BPA treatment. Two early behaviors (righting reflex and slant board behavior) were not altered by BPA treatment, although offspring preweaning body weight was significantly decreased by BPA treatment. In contrast, oral EE 2 treatment significantly decreased gestational and lactational body weight, birth weights, and preweaning body weights. The general lack of BPA effects is consistent with results from previous studies of oral BPA treatment. However, several endpoints measured here have not been previously described. These results indicate that the preweaning measures assessed here appear resistant to interference by these oral BPA doses.
BPA treatment had no effect on gestational or lactational body weights. This finding is similar to those of others using oral BPA doses ranging 0.05-320,000 lg/kg/day to rats (Cagen et al., 1999; Howdeshell et al., 2008; Kim et al., 2001; Kwon et al., 2000; Somm et al., 2009; Tyl et al., 2002) . Similarly, BPA treatment here had no effects on gestational food intake or gestational or lactational water intake. There were four LDs (10, [15] [16] and 18) in which the low-BPA group consumed less food than the vehicle control group; however, this appeared to be neither a consistent effect nor dose related. This lack of BPA treatment effects on dam food and water intake is similar to those reports using BPA doses ranging 1.0-4022 lg/kg/day to rats (Cagen et al., 1999; Kim et al., 2001; Somm et al., 2009) .
Absolute AGD can be sensitive to prenatal treatment with endocrine disrupters (Ball et al., 2010; Delclos et al., 2009; Taxvig et al., 2008) ; previous studies, however, have indicated no effects on absolute AGD of rats prenatally treated with 2-384,400 lg/kg/day BPA (Howdeshell et al., 2008; Ryan et al., 2010; Takagi et al., 2004; Tinwell et al., 2002) . Furthermore, measures of AGD index, which normalizes AGD to weight, were not altered at birth by oral BPA treatment at doses ranging 0.2-200 lg/kg/day (Ema et al., 2001) . Thus, our finding that neither absolute AGD nor AGD index was sensitive to prenatal BPA treatment is confirmatory and not surprising.
Birth weights of offspring exposed in utero to BPA were not affected by treatment; however, preweaning body weights were decreased in both sexes relative to the vehicle control group (maximum 10% decrease in low-dose BPA PND 5 females). Because preweaning body weights of the ungavaged naive control group were decreased relative to vehicle controls, this Note. There was a significant effect of treatment on T3 concentrations (F(5, 149) ¼ 2.46, p < 0.035); however, pairwise comparisons to the vehicle control group did not indicate that any treatment group was significantly different. A marginally significant treatment effect on corticosterone levels (F(5, 149) ¼ 2.25, p < 0.052) indicated somewhat higher levels in the high-dose EE 2 group. A marginal effect of sex (F(1, 149) ¼ 3.74, p < 0.055) on testosterone levels indicated somewhat higher levels in males. Group sizes were 10-17 per group for males and 13-15 per group for females. a Of the 15 low BPA male samples for testosterone, only 6 were above the detection limit (4.0 ng/dl) and of those 6, one sample was 176.1 and another was 37.8, thus resulting in the large SE. The sample that assayed at 37.8 had enough serum remaining to reassay several months later in duplicate and the levels were 37.8 and 36.6, indicating that the original high level was correct. The sample that originally assayed at 176.1 did not have enough remaining serum to reassay. 156 FERGUSON, LAW, AND ABSHIRE requires a closer examination. Differences between offspring body weights of the naive control and vehicle control groups could be due to the carboxymethylcellulose vehicle. However, birth weights that included all pups/litter of the naive control and vehicle control groups were not significantly different. Still, the vehicle control group exhibited the highest birth weights of all groups, although these were only significantly different from the high-dose EE 2 group. Thus, prenatal treatment with carboxymethylcellulose appeared to have no or only minor effects on birth weight. With direct oral treatment of the offspring on PNDs 1-21, the naive control group weighed significantly less than the vehicle control group. An early study indicated that reproductive, developmental, and early behavioral outcomes (e.g., righting reflex) of rats were unaffected by oral treatment with a 2% aqueous CMC solution administered at 10 ml/kg/day (Fritz and Becker, 1981) . In adult rats, dietary CMC resulted in few effects at doses of 1.36-1.57 g/kg/day (Bar et al., 1995) . Here, the CMC dose was 0.3% CMC at 5 ml/kg/day or 0.015 g/kg/day. Thus, the unusual finding of higher preweaning body weights in the vehicle control group relative to the naive control group remains unexplained (maximum 8% decrease in PND 7 males). The most consistent effect associated with 1.36-1.57 g/kg/day of dietary CMC was increased water intake by adult males, but not females, throughout the 11-week exposure, likely related to the increased sodium of the CMC diets (Bar et al., 1995) . Although it could be hypothesized that increased thirst in vehicle control offspring of the current study may have resulted in increased suckling and potentially increased body weight, four other treatment groups here also received the same daily dose of CMC (i.e., the BPA and EE 2 groups). Similar to the naive control group, those groups also exhibited decreased preweaning body weights relative to vehicle controls. A preliminary examination of postweaning body weights of the subjects of this study indicates that there are few, if any, significant differences between the naive and vehicle control groups (unpublished data), which would indicate this effect is either restricted to the preweaning period or perhaps a spurious effect. A larger ongoing study using identical vehicle and naive control groups will determine the replicability of this effect (Delclos, in preparation) .
Developmental landmarks (e.g., age at eye opening) were reported to be unaffected by oral BPA treatment at doses ranging 0.2-200 lg/kg/day to rats (Ema et al., 2001) , and similar findings were noted here. Two additional landmarks measured here, age at bilateral ear canal opening and fur development were not altered by BPA treatment. Ages at eye and ear canal opening as well as fur development for the vehicle control group were similar to those reported in the literature for the Sprague-Dawley strain (e.g., Matta and Elberger, 2007; National Toxicology Program, 2010) . Furthermore, no male offspring exhibited signs of nipple retention, replicating previous findings in rats using dietary BPA doses ranging 1-500,000 lg/kg/day (Tyl et al., 2002) . Thus, the new findings here that BPA had no effects on ear canal opening or fur development provide additional support that oral BPA treatment does not affect these early landmarks.
Although performance of the righting reflex was previously investigated in BPA-treated rats (Ema et al., 2001; Stump et al., 2010) , our laboratory uses a more detailed methodology. Specifically, rather than recording the behavior as a success or failure, the latency to complete the behavior over consecutive days was measured. This allows a more thorough detection of potential subtle alterations on specific days. Still BPA treatment had no significant effects on righting latencies. Thus, it would appear that this early behavior is resistant to oral BPA treatment in two rodent species at oral doses spanning 10-150,000 lg/kg/day (Ema et al., 2001; Palanza et al., 2002; Stump et al., 2010) . As expected and previously reported (Ferguson et al., 2003b (Ferguson et al., , 2010 , latencies here were shorter with increasing age and males were faster to right.
Similar to measurement of the righting reflex, latency to complete an 180°turn on the slant board over consecutive days was measured. However, BPA treatment did not alter the latency to turn, a finding similar to that of Ema et al. (2001) in which oral BPA doses of 0.2-200 lg/kg/day had no effect on age at achieving this behavior in rats. The finding here that oral BPA treatment did not alter slant board behavior is further strengthened by our previous reports indicating the sensitivity of this behavior to strain differences (Ferguson et al., 2003b) , developmental synthetic glucocorticoid treatment (Ferguson et al., 2001) , and developmental NMDA antagonist treatment (Boctor et al., 2008) .
BPA treatment had no effects on hormonal measures or brain weights at weaning. Although measures of testosterone, estradiol, LH, T3, T4, and corticosterone are typical, levels of ghrelin and leptin were also measured here. Ghrelin and leptin are implicated in appetite and obesity (Diéguez et al., 2010; Hassouna et al., 2010; Myers et al., 2010; Suzuki et al., 2010) , and BPA has been suggested to act as an obesogen (Grün, 2010; Newbold, 2010; Newbold et al., 2009) . Furthermore, plasma leptin levels of mice were elevated during pregnancy after subcutaneous BPA treatment (100 lg/kg) (Alonso-Magdalena et al., 2010). Here, PND 21 serum levels of ghrelin and leptin in offspring were not altered by BPA treatment. Because hormone levels are age dependent, direct crossstudy comparisons are difficult. However, similar to our findings, subcutaneous injections of 50 or 20,000 lg/kg/day BPA on PNDs 1-7 did not alter serum estradiol levels in female rats at weaning (Monje et al., 2007) . In PND 30, male offspring of rats sc injected with 2 lg/kg/day BPA from GD 10 to LD 7, LH levels were higher and testosterone levels were lower (Bai et al., 2011) . Similarly, PND 35 male offspring of rats that consumed approximately 2500 lg/kg/day BPA in drinking water throughout gestation and lactation had lower LH and testosterone levels (Cardoso et al., 2010) . Here, there were no effects of BPA treatment on LH levels; however, differences in age and dose/route of BPA administration do not allow a straightforward comparison with the levels reported here.
FEW EFFECTS OF DEVELOPMENTAL BPA OR EE 2 EE 2 was selected as a reference estrogen for this study based on its previous use in studies of potential endocrine disrupters (Sahambi et al., 2010; Stoker et al., 2010) . The majority of the statistically significant effects in this study were noted in one or both EE 2 groups, indicating sensitivity to treatment with this compound. Several reports, however, have criticized use of the Sprague-Dawley strain in studies of potential estrogenic substances (e.g., Richter et al., 2007) , suggesting that this strain is less sensitive to estrogenic compounds. To the contrary, the current results imply this strain is quite sensitive to exogenously administered estrogens, and previous studies from the NCTR have indicated similar findings . Others have also discussed this issue and described the Sprague-Dawley strain as sensitive (Diel et al., 2004; Goodman et al., 2006) .
The findings here for EE 2 were similar to those described by others using oral treatment. Specifically, oral doses of 1.5-50 lg/kg/day decreased gestational weight gain in rats (Howdeshell et al., 2008) , and birth weight or PND 2 body weight of rats was decreased by oral doses of 10-50 lg/kg/ day EE 2 (Ferguson et al., 2003a; Howdeshell et al., 2008; National Toxicology Program, 2010 ), although others have described a lack of treatment effects on female birth weights at doses of 0.05-15 lg/kg/day EE 2 (Ryan et al., 2010) . Furthermore, oral treatment with 0.5-50 lg/kg/day EE 2 did not alter AGD in rats Howdeshell et al., 2008; Sawaki et al., 2003) . Performance of the righting reflex or slant board turn behavior has not been described after developmental estrogen treatment; however, developmental treatment with the fungicide fenarimol that has estrogenic properties was described to alter the righting reflex in rats (de Castro et al., 2007) , whereas exposure to different dietary levels of phytoestrogens had no effects on the same behavior in rats (Becker et al., 2005) .
In summary, oral BPA treatment had no consistent or doserelated effects on various gestational or lactational measures. Furthermore, offspring physical and behavioral development seemed impervious to BPA-induced alterations, with perhaps the exception of preweaning body weight. Conversely, oral treatment with the reference estrogen EE 2 decreased gestational and lactational body weight and offspring birth weight but did not alter offspring preweaning behavior. These data provide additional evidence that relatively low oral doses of BPA are not associated with early alterations. A variety of behaviors were assessed in the offspring described here after weaning and through adulthood, including measures of spatial learning/ memory, play behavior, and activity. Those data will be reported separately. Such measures may prove to be more sensitive to BPA treatment.
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